Black people with multiple sclerosis (MS) may face higher mortality rates and more severe symptoms than white people, yet 98% of participants in recent MS drug trials were white. This lack of ...

The first participant has been dosed in an investigator-led Phase 2 trial testing pegsebrenatide as a potential treatment for ...

More than 300 participants raised more than $200,000 at Walk MS Richmond at Richmond Raceway. The CBS 6 team rides again May ...

Closing the gap in Multiple Sclerosis care here in Northwest Arkansas, that’s the mission behind the Rampy MS Research ...

The International Progressive MS Alliance announces the MS Clinical and Imaging Data Resource (MS CIDR) is now accepting ...

Nearly one million people in the United States live with multiple sclerosis, but according to Marcie Fitzgerald, that number ...

Add Yahoo as a preferred source to see more of our stories on Google. When you buy through links on our articles, Future and its syndication partners may earn a commission. Dr. Alberto Ascherio (left) ...

Mark Milner is studying the switch between healthy and inflammatory microglia cells that could lead to the first treatment to ...

NASHVILLE, Tennessee — For the first time, the majority of patients with multiple sclerosis (MS) in the United States are, or soon will be, over age 55, a phenomenon that's driving a shift in ...

Clinicians and researchers have suspected for years that an aggressive, less-common form of multiple sclerosis (MS) is likely a distinct form of the disease. Now, new research conducted using a more ...

Hundreds of bikers are going the extra mile to fight multiple sclerosis on May 2 and 3. The annual event not only brings ...

Researchers are studying many antioxidants, including alpha-lipoic acid, for their potential roles in relieving symptoms associated with neurodegenerative conditions such as multiple sclerosis (MS).